Pages that link to "Q44608057"
Jump to navigation
Jump to search
The following pages link to Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins (Q44608057):
Displaying 50 items.
- O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function (Q24293011) (← links)
- Genetic diversity between and within the arenavirus species indigenous to western Venezuela (Q24657349) (← links)
- Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system (Q27334626) (← links)
- Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins (Q27486886) (← links)
- Epitopes functional in neutralization of varicella-zoster virus (Q27488400) (← links)
- Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: Implications for receptor usage and pathogenicity (Q27489608) (← links)
- Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits (Q28602816) (← links)
- Progress towards recombinant anti-infective antibodies (Q33568256) (← links)
- Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers (Q33652265) (← links)
- Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics (Q33835007) (← links)
- Diversity among Tacaribe serocomplex viruses (Family Arenaviridae) associated with the southern plains woodrat (Neotoma micropus) (Q33950619) (← links)
- LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration (Q34338137) (← links)
- Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins (Q34651454) (← links)
- Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization (Q34719449) (← links)
- Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy (Q34805961) (← links)
- Viral persistence in vivo through selection of neutralizing antibody-escape variants. (Q35080884) (← links)
- Infection of dendritic cells by lymphocytic choriomeningitis virus (Q35149902) (← links)
- Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. (Q35832377) (← links)
- Virus-specific, CD8 major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice (Q35898366) (← links)
- Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread. (Q36228781) (← links)
- Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus (Q36314976) (← links)
- Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells (Q36369072) (← links)
- Impairment of CD4( ) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants (Q36376194) (← links)
- Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus (Q36687261) (← links)
- Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever (Q36694022) (← links)
- Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection (Q36694204) (← links)
- Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection (Q36698867) (← links)
- Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus (Q36796002) (← links)
- Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. (Q36831093) (← links)
- Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus (Q36875351) (← links)
- Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV (Q37095226) (← links)
- Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus (Q37336878) (← links)
- Genetic diversity among Bolivian arenaviruses (Q37482648) (← links)
- Arenavirus genetic diversity and its biological implications (Q37491440) (← links)
- Substitutions in the Glycoprotein (GP) of the Candid#1 Vaccine Strain of Junin Virus Increase Dependence on Human Transferrin Receptor 1 for Entry and Destabilize the Metastable Conformation of GP (Q39462623) (← links)
- Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins (Q39778977) (← links)
- New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. (Q40051850) (← links)
- Receptor use by pathogenic arenaviruses (Q40263268) (← links)
- Characterization of the cellular receptors for the South American hemorrhagic fever viruses Junin, Guanarito, and Machupo. (Q40298008) (← links)
- Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses. (Q40366469) (← links)
- Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan (Q40509716) (← links)
- Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan. (Q40545207) (← links)
- Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions (Q40630442) (← links)
- Protein-protein interactions in lymphocytic choriomeningitis virus (Q41671793) (← links)
- Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus (Q41729569) (← links)
- Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism (Q41980779) (← links)
- Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1. (Q44525484) (← links)
- Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. (Q45616527) (← links)
- Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera (Q45779125) (← links)
- Autoantibodies against mitochondrial glycerophosphate dehydrogenase in patients with IDDM (Q74245756) (← links)